Healthcare Industry Glucose Biosensors Market Analysis Report | Page 2

Your Catalyst To a Lucrative Business
End-users are home care diagnostics , hospitals , and others . Others include diagnostic laboratories , research institutes , and clinical . Home care diagnostics held over 46 % market shares in 2015 . This segment comprises the adoption hand-held glucose meters . These devices deliver quick & efficient results and reduce the need for frequent hospital visits . ‘ Hospitals ’ may expand significantly over the next eight years . It could grow a 10.3 % CAGR from 2015 to 2022 .
Regions in the global Glucose Biosensors Market are North America , Latin America , Middle East & Africa ( MEA ), Asia Pacific , and Europe . North America dominated the worldwide market with nearly 37 % shares in 2015 . Growing cases of diabetes coupled with technological advancements in the region can boost revenues during the forecast period . Europe may be the second largest market in terms of revenue after North America . Asia Pacific is expected to grow at a CAGR of 13 % from 2015 to 2022 . India & China jointly accounted for over 65 % of the global diabetic base in 2013 . This could benefit the worldwide market in the years ahead .
Major players in the glucose biosensor industry are LifeScan Inc ., Abbott Laboratories , F . Hoffmann-La Roche AG , and Bayer AG . These companies held over 70 % of the total market shares in 2014 . They focus on product development , partnerships , and collaborations for long term growth and market sustenance . For instance , LifeScan introduced a new glucose monitoring system , OneTouch Verio in 2015 . It measures glucose levels via a color-coded indicator .
Mayo Clinic , Gentag , NovioSense , and Fraunhofer Institute for Microelectronic Circuits & Systems entered a collaboration to fight against type 2 diabetes , in 2015 . They aim at equipping smartphones with low-cost diabetes monitoring systems . The technology thus developed may be employed in a number of diabetes applications , such as eye sensors , skin patches , long-terms implantable sensors and so on . All of these devices can be controlled via smartphones . Currently , carbon nanotubes are gaining popularity due to their exceptional physical and electrical properties . These nanotubes work well with glucose biosensors by providing support for enzyme control .
Browse Related Category Market Reports @ https :// www . hexaresearch . com / research-category / clinicaldiagnostics-industry
Follow Us :